Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?

Psychiatry Research

Volumn 169, Issue 1, 2009, Pages 7-11

  Petersen, Timothy ^a   Andreotti, Charissa F ^a   Chelminski, Iwona ^b   Young, Diane ^b   Zimmerman, Mark ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Comorbid anxiety disorders; Major depressive disorder; Treatment planning

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; STATISTICAL MODEL; TREATMENT PLANNING;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMORBIDITY; DATABASES, FACTUAL; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LOGISTIC MODELS; MALE; OUTPATIENTS; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY;

EID: 67651155746     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.10.036     Document Type: Article

References (24)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder (revision) (2000), APA, Washington, DC
2. Bakish D. The patient with comorbid depression and anxiety: the unmet need. Journal of Clinical Psychiatry 60 (1999) 20-24
3. Beck A.T. Cognitive Therapy of Depression (1979), Guilford Press, New York
4. Brown C., Schulberg H.C., Madonia M.J., Shear M.K., and Houck P.R. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. American Journal of Psychiatry 153 (1996) 1293-1300
5. Farabaugh A., Fava M., Mischoulon D., Sklarsky K., and Petersen T. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Comprehensive Psychiatry 46 (2005) 266-271
6. Fava M., Alpert J.E., Carmin C.N., Wisniewski S.R., Trivedi M.H., Biggs M.M., Shores-Wilson K., Morgan D., Schwartz T., Balasubramani G.K., and Rush A.J. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine 34 (2004) 1299-1308
7. Fava M., Rush A.J., Alpert J.E., Carmin C.N., Balasubramani G.K., Wisniewski S.R., Trivedi M.H., Biggs M.M., and Shores-Wilson K. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Canadian Journal of Psychiatry 51 (2006) 823-835
8. Feske U., Frank E., Kupfer D.J., Shear M.K., and Weaver E. Anxiety as a predictor of response to interpersonal psychotherapy for recurrent major depression: an exploratory investigation. Depression and Anxiety 8 (1998) 135-141
9. Gorman J.M. Comorbid depression and anxiety spectrum disorders. Depression and Anxiety 4 (1996-1997) 160-168
10. Hoehn-Saric R., Ninan P., Black D.W., Stahl S., Greist J.H., Lydiard B., McElroy S., Zajecka J., Chapman D., Clary C., and Harrison W. Multicenter double-blind comparison or sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Archives of General Psychiatry 57 (2000) 76-82
11. Joffe R.T., Bagby R.M., and Levitt A. Anxious and nonanxious depression. American Journal of Psychiatry 150 (1993) 1257-1258
12. Kuzel R. Treating comorbid depression and anxiety. Journal of Family Practice 43 (1996) S45-S53
13. Lesser I.M., Leuchter A.F., Trivedi M.H., Davis L.L., Wisniewski S.R., Balasubramani G.K., Fava M., and Rush A.J. Insured and non-insured depressed outpatients: how do they compare?. Annals of Clinical Psychiatry 19 (2007) 73-82
14. Nutt D. Management of patients with depression associated with anxiety symptoms. Journal of Clinical Psychiatry 58 (1997) 11-16
15. Pollack M.H. Comorbid anxiety and depression. Journal of Clinical Psychiatry 66 (2005) 22-29
16. Rihmer Z. Suicide risk in mood disorders. Current Opinions in Psychiatry 20 (2007) 17-22
17. Rush A.J., Fava M., Wisniewski S.R., Lavori P.W., Trivedi M.H., Sackeim H.A., Thase M.E., Nierenberg A.A., Quitkin F.M., Kashner T.M., Kupfer D.J., Rosenbaum J.F., Alpert J., Stewart J.W., McGrath P.J., Biggs M.M., Shores-Wilson K., Lebowitz B.D., Ritz L., Niederehe G., and STAR*D Investigators Group. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Controlled Clinical Trials 25 (2004) 119-142
18. Souery D., Oswald P., Massat I., Bailer U., Bollen J., Demyttenaere K., Kasper S., Lecrubier Y., Montgomery S., Serretti A., Zohar J., Mendlewicz J., and Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder; results from a European multicenter study. Journal of Clinical Psychiatry 68 (2007) 1062-1070
19. STATA Version 9.2 SE 2007. Statacorp LP. 2007.
20. Tollefson G.D., Holman S.L., Sayler M.E., and Potvin J.H. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. Journal of Clinical Psychiatry 55 (1994) 50-59
21. Zimmerman M., and Chelminski I. Clinician recognition of anxiety disorders in depressed outpatients. Journal of Psychiatric Research 37 (2003) 325-333
22. Zimmerman M., and Mattia J.I. The reliability and validity of a screening questionnaire for 14 DSM-IV axis I disorders (The Psychiatric Diagnostic Screening Questionnaire). Journal of Clinical Psychiatry 60 (1999) 677-683
23. Zimmerman M., McDermut W., and Mattia J.I. Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. American Journal of Psychiatry 157 (2000) 1337-1340
24. Zimmerman M., Posternak M.A., and Chelminski I. Symptom severity and exclusion from antidepressant efficacy trials. Journal of Clinical Psychopharmacology 22 (2002) 610-614